Citadel Advisors »

Abvc Biopharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Abvc Biopharma (ABVC) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Abvc Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Abvc Biopharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abvc Biopharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $32k 27k 1.16
2023-09-30 $16k 16k 1.04

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Abvc Biopharma

Chase Investment Counsel Corp.
Vanguard Group
Citadel Advisors
Spotlight Asset Group
Royal Bank of Canada
Wells Fargo & Company

View all funds holding Abvc Biopharma